Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
07/2003
07/03/2003WO2003053969A1 Imidazoquinoline derivatives
07/03/2003WO2003053967A1 Aroyl pyridinones
07/03/2003WO2003053965A1 Salicylate salt of a thiazolidinedione derivative
07/03/2003WO2003053963A1 Novel pharmaceutical
07/03/2003WO2003053955A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases
07/03/2003WO2003053944A1 Pancreatic lipase inhibitor compounds, their synthesis and use
07/03/2003WO2003053933A1 Heteroaryl-substituted aminocyclohexane derivatives
07/03/2003WO2003053928A1 Serotonine reuptake inhibitor
07/03/2003WO2003053927A1 Piperazine derivative
07/03/2003WO2003053926A1 Novel phenylalanine derivative
07/03/2003WO2003053925A1 Pyrrolidine-2-ones as factor xa inhibitors
07/03/2003WO2003053922A2 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
07/03/2003WO2003053919A1 Substituted cyclohexane derivatives
07/03/2003WO2003053915A2 Compounds for the treatment of inflammatory disorders
07/03/2003WO2003053565A1 Adsorbent for phosphoric acid
07/03/2003WO2003053454A1 Compositions incorporating (-)-hydroxycitric acid, chromium, and gymnemic acid, and related methods for promoting healthy body weight and improving related health factors
07/03/2003WO2003053451A1 Use of ionic and non-ionic cellulose ethers for producing a gel-like agent for preventing the resorption of fats from the gastro-intestinal tract
07/03/2003WO2003053441A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
07/03/2003WO2003053434A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
07/03/2003WO2003053400A1 Formulation & dosage form for the controlled delivery of therapeutic agents
07/03/2003WO2003053368A2 Chalcone derivatives and their use to treat diseases
07/03/2003WO2003053366A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use
07/03/2003WO2003053361A2 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE
07/03/2003WO2003053358A2 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
07/03/2003WO2003053354A2 Fused cyclic modulators of nuclear hormone receptor function
07/03/2003WO2003053352A2 Therapeutic compounds for treating dyslipidemic conditions
07/03/2003WO2003053346A2 Systems and methods for treating patients with processed lipoaspirate cells
07/03/2003WO2003053339A2 Insulin molecule having protracted time action
07/03/2003WO2003053336A2 Methods for the treatment of peripheral neural and vascular ailments
07/03/2003WO2003053219A2 Methods for slowing senescence and treating and preventing diseases associated with senescence
07/03/2003WO2003053169A1 Soft drink replacer
07/03/2003WO2003053167A1 Composition for promotion of bone growth and maintenance of bone health
07/03/2003WO2003053165A1 Matrix-forming composition containing pectin
07/03/2003WO2003053163A2 Salt composition with low sodium chloride and high organic potassium salt content and uses thereof
07/03/2003WO2003030823A3 Combinations for the treatment of immunoinflammatory disorders
07/03/2003WO2003020201A3 Pre-mixes of glp-1 and basal insulin
07/03/2003WO2003013440A3 Treatment and prevention of heat shock protein-associated diseases and conditions
07/03/2003WO2002084249A3 Therapeutic and diagnostic uses of antibody specificity profiles
07/03/2003WO2002070657A3 93870, a human g-protein coupled receptor and uses therefor
07/03/2003WO2002058734A3 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
07/03/2003WO2002058732A3 Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
07/03/2003WO2002050279A3 Nucleic acid-associated proteins
07/03/2003WO2002024754A8 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative
07/03/2003US20030125569 Use of packing strip as a holographic data carrier
07/03/2003US20030125565 2,5-dioxoimidazolidine or 2-thio-5-oxoimidazolidine derivatives suitable for the therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorder
07/03/2003US20030125559 Methods for synthesizing ether compounds and intermediates therefor
07/03/2003US20030125509 Indomethacin entrapped within polysaccaride (dextran) or proteins
07/03/2003US20030125368 (1,2,4) triazol-1-yl)-benzenesulfonyl derivatives useful to treat osteoarthritis, rheumatoid arthritis, colon cancer and Alzheimer's disease, in mammals; cyclooxygenase (COX)-2 inhibitor
07/03/2003US20030125361 1H-benzo(g)indazole compounds as anticarcinogenic agents and also treat arthritis
07/03/2003US20030125360 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases
07/03/2003US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases
07/03/2003US20030125342 6-substituted biaryl purine derivatives as potent cyclin/CDK inhibitors and antiproliferative agents
07/03/2003US20030125334 5-HT receptor ligands and uses thereof
07/03/2003US20030125332 Pyrazolo(3,4-c)pyridazin-3-ylamine derivatives; glycogen synthase kinase-3 (gsk-3); treatment and prevention of diabetes and Alzheimer's disease
07/03/2003US20030125330 Anxiolytics and antidepressants
07/03/2003US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents
07/03/2003US20030125316 Cardiovascular disorders including atherosclerosis and other coronary artery disease; anticholesterol agents; antilipemia agents; nontoxic; prophylactic; e.g., 2,3,4,5-tetrahydro-1-benzothiepine 1,1-dioxide and nicotinic acid or nigeritrol
07/03/2003US20030125310 Combine solutions of each vitamin, i.e, K, D's, E and A, in water or an inert oil and emulsify using a protective colloid; drying; fineness; discoloration inhibition; homogeneity; oxidation resistance
07/03/2003US20030125309 Cyclic ether vitamin D3 compounds, 1alpha(OH) 3-epi- vitamin D3 compounds and uses thereof
07/03/2003US20030125301 Blocking postprandial glycemic response by feeding a dual induced viscosity fiber system of soluble fiber, water-insoluble, acid- soluble metal or metal compound (calcium carbonate) and a hydrolyzed starch; dietetics;
07/03/2003US20030125294 Selective toxin expression in angiogenic endothelial cells
07/03/2003US20030125259 Administering to the mammal a therapeutically acceptable amount of a octa or nonapeptide compound to inhibit the angiogenesis
07/03/2003US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein
07/03/2003US20030125237 Controlled release preparation of insulin and its method
07/03/2003US20030125236 Phospholipids, bioactive agent and excipients and the pulmonary delivery thereof. Dry powder inhaled insulin formulations are disclosed. Improved formulations comprising DPPC, insulin and sodium citrate which are useful in the
07/03/2003US20030124721 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
07/03/2003US20030124617 Antiinflammatory agents; antiarthritic agents; interleukins; antiallergens; bronchodilator agents
07/03/2003US20030124602 Tumour suppresor and uses thereof
07/03/2003US20030124598 PGC-1beta, a novel PGC-1 homologue and uses therefor
07/03/2003US20030124540 Interventions to mimic the effects of calorie restriction
07/03/2003US20030124222 Oilseed processing
07/03/2003US20030124208 Alpha-amylase activity inhibitors
07/03/2003US20030124193 Atomizing nozzles include a liquid nozzle adapted to disperse a supply of liquid and a gas nozzle adapted to disperse a supply of gas; spray drying at a commercial plant scale.
07/03/2003US20030124150 Kit for reducing aching
07/03/2003US20030124129 Angiopoietin-2 specific binding agents
07/03/2003US20030124104 A Bacillus bacterium that forms a spore that is germination-competent in the presence of a bile acid; colonizing intestinal tissue by administering bacterial cells or spores to the animal
07/03/2003US20030124088 Preparation for preventing bile acid diarrhea
07/03/2003CA2849201A1 Adipose-derived cell processing unit
07/03/2003CA2471461A1 Pyrrolidine-2-ones as factor xa inhibitors
07/03/2003CA2471107A1 Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators
07/03/2003CA2471098A1 Pancreatic lipase inhibitor compounds, their synthesis and use
07/03/2003CA2471085A1 Aroyl pyridinones
07/03/2003CA2471081A1 Formulation & dosage form for the controlled delivery of therapeutic agents
07/03/2003CA2470931A1 Chalcone derivatives and their use to treat diseases
07/03/2003CA2470856A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
07/03/2003CA2470808A1 Piperazine derivative
07/03/2003CA2470612A1 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
07/03/2003CA2470603A1 Methods for the treatment of peripheral neural and vascular ailments
07/03/2003CA2470594A1 Leptin proteins
07/03/2003CA2470591A1 Therapeutic compounds for treating dyslipidemic conditions
07/03/2003CA2470576A1 Methods for slowing senescence and treating and preventing diseases associated with senescence
07/03/2003CA2469551A1 Composition for promotion of bone growth and maintenance of bone health
07/03/2003CA2469370A1 Adipose-derived cell processing unit
07/03/2003CA2468100A1 Insulin molecule having protracted time action
07/03/2003CA2468083A1 Use of heterocyclic carboxamides to treat anemia
07/03/2003CA2463427A1 Compositions incorporating (-)-hydroxycitric acid, chromium, and gymnemic acid, and related methods for promoting healthy body weight and improving related health factors
07/03/2003CA2462587A1 Modulating insulin receptor signaling through targeting facl
07/03/2003CA2448811A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases
07/02/2003EP1323734A1 Irap-binding protein
07/02/2003EP1323711A1 Novel phenylalanine derivatives
1 ... 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 ... 1298